A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Completed
Hormos Medical
Phase 3
2006-01-01
The purpose of this study is to determine whether ospemifene is more effective than placebo
in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women.
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Completed
QuatRx Pharmaceuticals
Phase 3
2006-01-01
The purpose of this study is to determine whether ospemifene is more effective than placebo
in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women.
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Completed
Shionogi
Phase 3
2006-01-01
The purpose of this study is to determine whether ospemifene is more effective than placebo
in the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women.
A Clinical Study to Evaluate the Safety of Ospemifene
Completed
Hormos Medical
Phase 3
2007-10-01
The purpose of this study is to determine the efficacy and long-term safety of 60mg
ospemifene in the treatment of VVA in postmenopausal women with intact uterus.
A Clinical Study to Evaluate the Safety of Ospemifene
Completed
QuatRx Pharmaceuticals
Phase 3
2007-10-01
The purpose of this study is to determine the efficacy and long-term safety of 60mg
ospemifene in the treatment of VVA in postmenopausal women with intact uterus.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
